Published in J Urol on January 01, 2000
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort. Am J Epidemiol (2009) 1.92
HoLEP has come of age. World J Urol (2014) 1.52
Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia? Am J Epidemiol (2013) 1.41
Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet (2002) 1.41
Intravesical prostatic protrusion in men in Olmsted County, Minnesota. J Urol (2009) 1.08
Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes. Am J Epidemiol (2011) 1.00
Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World J Urol (2011) 0.99
Prospective factor analysis of alpha blocker monotherapy failure in benign prostatic hyperplasia. Korean J Urol (2010) 0.88
Benign prostatic hyperplasia: does prostate size matter? Rev Urol (2003) 0.87
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients. BJU Int (2012) 0.86
5-alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia. Rev Urol (2003) 0.85
Practice patterns regarding prostate cancer and benign prostatic hyperplasia in Japanese primary care practitioners. Int J Urol (2007) 0.83
Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times. BJU Int (2009) 0.81
Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men. J Urol (2011) 0.79
Patterns in the diagnosis and management of benign prostatic hyperplasia in a country that does not have country-specific clinical practice guidelines. Yonsei Med J (2007) 0.79
Early sequential changes in bladder function after partial bladder outlet obstruction in awake sprague-dawley rats: focus on the decompensated bladder. Korean J Urol (2011) 0.79
Reducing the risk of benign prostatic hyperplasia progression. Rev Urol (2002) 0.78
Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH). Ther Clin Risk Manag (2007) 0.78
5-alpha-Reductase Inhibitors Prevent the Progression of Benign Prostatic Hyperplasia. Rev Urol (2003) 0.78
Risk of Fractures and Falls during and after 5-α Reductase Inhibitor Use: A Nationwide Cohort Study. PLoS One (2015) 0.77
Identification of the patient with enlarged prostate: diagnosis and guidelines for management. Osteopath Med Prim Care (2007) 0.75
Preventing progression in men with mild symptoms of benign prostatic hyperplasia: a potential role for phytotherapy. Rev Urol (2004) 0.75
Medical treatment of benign prostatic hyperplasia. Postgrad Med J (2007) 0.75
Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol (2000) 7.71
Mink cell line Mv 1 Lu (CCL 64). Focus formation and the generation of "nonproducer" transformed cell lines with murine and feline sarcoma viruses. Virology (1974) 6.53
Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges. JAMA (1993) 5.77
Age-specific reference ranges for prostate-specific antigen in black men. N Engl J Med (1996) 5.68
Hospital characteristics and mortality rates. N Engl J Med (1989) 4.97
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation (1998) 4.63
Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA (1992) 4.36
The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol (1993) 3.66
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med (2011) 3.63
Natural history of prostatism: risk factors for acute urinary retention. J Urol (1997) 3.59
Comparison of self-reported and medical record health care utilization measures. J Clin Epidemiol (1996) 3.47
Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am J Epidemiol (1999) 3.41
Infectious C-type virus isolated from a baboon placenta. Nature (1974) 3.32
Incidence of reading disability in a population-based birth cohort, 1976-1982, Rochester, Minn. Mayo Clin Proc (2001) 3.18
A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol (1996) 3.09
A distinct class of inducible murine type-C viruses that replicates in the rabbit SIRC cell line. Proc Natl Acad Sci U S A (1974) 3.00
Software for optimal matching in observational studies. Epidemiology (1996) 2.84
Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res (1997) 2.80
The genetics of hyphal fusion and vegetative incompatibility in filamentous ascomycete fungi. Annu Rev Genet (2000) 2.77
Isolation from the asian mouse Mus caroli of an endogenous type C virus related to infectious primate type C viruses. Proc Natl Acad Sci U S A (1975) 2.71
Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. JAMA (1995) 2.70
The impact of requiring patient authorization for use of data in medical records research. J Fam Pract (1998) 2.64
Interpreting results of prostate-specific antigen testing for early detection of prostate cancer. J Gen Intern Med (1996) 2.57
Type C viruses of baboons: isolation from normal cell cultures. Cell (1974) 2.55
A population-based study of school scoliosis screening. JAMA (1999) 2.54
Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med (1999) 2.54
Nucleic acid homology of murine type-C viral genes. J Virol (1974) 2.51
Clinical features of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol (1996) 2.48
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46
Sex differences in evaluation and outcome of unstable angina. JAMA (2000) 2.33
Geographic variation of inflammatory bowel disease within the United States. Gastroenterology (1991) 2.33
Potential influence of migration bias in birth cohort studies. Mayo Clin Proc (1998) 2.19
Low bone mineral density and risk of fracture in white female nursing home residents. JAMA (2000) 2.15
A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men. Arch Fam Med (1993) 2.05
Maternal recall of distant pregnancy events. J Clin Epidemiol (1998) 1.92
Twin studies of immunogenicity--determining the genetic contribution to vaccine failure. Vaccine (2001) 1.88
S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens. Int J Cancer (1974) 1.84
Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men. Br J Urol (1995) 1.82
Nucleic acid homology of murine xenotropic type C viruses. J Virol (1975) 1.82
Characterization of a type C virus released from the porcine cell line PK(15). Virology (1974) 1.81
A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol (2000) 1.81
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC. J Clin Pathol (2000) 1.81
Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol (2001) 1.79
Mammalian cells in culture frequently release type C viruses. Science (1973) 1.79
Body fat distribution and male/female differences in lipids and lipoproteins. Circulation (1990) 1.79
Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol (1997) 1.78
Identification of an association between HLA class II alleles and low antibody levels after measles immunization. Vaccine (2001) 1.77
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol (1994) 1.75
Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate. J Urol (1995) 1.75
Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med (1988) 1.73
Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men. J Urol (1996) 1.73
Trends in heart disease deaths in Olmsted County, Minnesota, 1979-1994. Mayo Clin Proc (1999) 1.72
Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst (1999) 1.70
Use of echocardiography in the management of congestive heart failure in the community. J Am Coll Cardiol (1999) 1.69
Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology (1998) 1.68
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
Validation of a new quality of life questionnaire for benign prostatic hyperplasia. J Clin Epidemiol (1992) 1.65
Effects of self-perceived hair loss in a community sample of men. Dermatology (1998) 1.64
Chromophobe cell renal carcinoma: clinicopathological features of 50 cases. J Urol (1995) 1.63
Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group. Pediatr Infect Dis J (1998) 1.63
Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995. Am J Hematol (1999) 1.60
Is school vision screening effective? J Sch Health (1996) 1.59
The prevalence of osteoporosis in nursing home residents. Osteoporos Int (1999) 1.59
Impact of arterial surgery and balloon angioplasty on amputation: a population-based study of 1155 procedures between 1973 and 1992. J Vasc Surg (1997) 1.58
Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology (1998) 1.57
Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with Type 2 diabetes in UK primary care. Diabet Med (2007) 1.57
Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol (1999) 1.53
Japanese men have smaller prostate volumes but comparable urinary flow rates relative to American men: results of community based studies in 2 countries. J Urol (1996) 1.53
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res (1995) 1.52
Endogenous primate and feline type C viruses. Cold Spring Harb Symp Quant Biol (1975) 1.51
The treatment of Graves' ophthalmopathy in an incidence cohort. Am J Ophthalmol (1996) 1.49
Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol (1999) 1.48